In asthma patients, the interaction between HDAC8 / Gal3 increases the CD163 expression; therefore, given the role of CD163 in M2 differentiation, and the role of M2 cells in Th2 differentiation, CD163 in asthma can be considered as a target for the targeted therapy route [21]. This evidence concerns the gene LGALS3 and asthma.